ArticleNature2023
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Open access · hybridFull text readPublished Erratum
In one paragraph
Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Pulsatilla Saponins Inhibit Experimental Lung Metastasis of Melanoma via Targeting STAT6-Mediated M2 Macrophages Polarization.Molecules (Basel, Switzerland) · 2023Article
Corrections and comments
- Erratum for
Authors and funding
40 authors at 3 institutions in 1 country.
Rodabe N Amaria *Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. rnamaria@mdanderson.org.ORCID http://orcid.org/0000-0001-6876-278X
Michael Postow *Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
Elizabeth M Burton *Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Michael T TetzlaffDepartment of Pathology, The University of California San Francisco, San Francisco, CA, USA.
Merrick I RossDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.ORCID http://orcid.org/0000-0002-7787-0421
Carlos Torres-CabalaDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-7422-0661
Isabella C GlitzaDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-4530-7765
Fei DuanDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Denái R MiltonDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Klaus BusamDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-0888-9601
Lauren SimpsonDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jennifer L McQuadeDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-2393-2172
Michael K WongDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jeffrey E GershenwaldDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Jeffrey E LeeDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.ORCID http://orcid.org/0000-0001-6010-5590
Ryan P GoepfertDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Emily Z KeungDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Sarah B FisherDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Allison Betof-WarnerDepartment of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0001-6422-2997
Alexander N ShoushtariDepartment of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0002-8065-4412
Margaret CallahanDepartment of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0002-9087-0012
Daniel CoitDepartment of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Edmund K BartlettDepartment of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Danielle BelloDepartment of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Parisa MomtazDepartment of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
Courtney NicholasDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-8596-0200
Aidi GuDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xuejun ZhangDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brinda Rao KoriviDepartment of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Madhavi PatnanaDepartment of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-8135-8001
Sapna P PatelDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-1339-1517
Adi DiabDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Anthony LucciDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Victor G PrietoDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-9204-7161
Michael A DaviesDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0977-0912
James P AllisonDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Padmanee SharmaDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4658-055X
Jennifer A WargoDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.ORCID http://orcid.org/0000-0003-3438-7576
Charlotte AriyanDepartment of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hussein A TawbiDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-1942-851X
The University of Texas MD Anderson Cancer Center · USMemorial Sloan Kettering Cancer Center · USUniversity of California, San Francisco · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What Socratic holds
Textfull text, public
LicenceCC BY
identifiers read1
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.